eli lilly ceo: we expect to launch five new medicines in 2022
Published 2 years ago • 8.1K plays • Length 5:50Download video MP4
Download video MP3
Similar videos
-
6:43
eli lilly ceo on weight loss drugs outlook: our top priority is making more product
-
2:22
eli lilly ceo: we have 11 pipeline projects in obesity
-
4:52
eli lilly ceo: we know there's high demand for weight-loss drugs and we're ready to meet it
-
4:22
fda approves a new alzheimer's drug from eli lilly
-
5:33
eli lilly ceo david ricks on 3-year obesity drug study: this is a profound result
-
1:41
eli lilly to build $4.5 billion research and manufacturing center to propel drug pipeline
-
4:26
eli lilly ceo david ricks breaks down second-quarter earnings and drug pipeline
-
6:08
eli lilly ceo on slashing insulin prices, approval timelines for weight-loss and alzheimer's drugs
-
30:33
eli lilly ceo dave ricks on revolutionizing healthcare and medicine
-
3:11
eli lilly to build $4.5 billion medicine foundry in lebanon
-
34:06
interview tips with eli lilly
-
4:14
eli lilly ceo david ricks on glp-1 and obesity drugs
-
5:24
eli lilly goes direct-to-consumer on weight loss drugs: what patients and investors need to know
-
4:30
eli lilly ceo on fda approval pathway for alzheimer's drugs
-
3:13
eli lilly ceo: we see a path to an alzheimer's disease-modifying drug
-
2:00
eli lilly is one of our favorites in 2022: bank of america pharma analyst
-
3:14
eli lilly ceo on raising $1b for antibiotic research: goal is to have two to four new antibiotics
-
1:54
coronavirus: eli lilly launches first human trial of a new type of treatment
-
6:49
coronavirus: eli lilly ceo david ricks on development of therapies
-
2:13
eli lilly ceo on covid antibody treatment's effectiveness against mutations
-
4:03
eli lilly ceo: alzheimer's drug trial shows slowed disease progression by 40-60% in early patients
-
0:55
eli lilly ceo on compounded versions of weight loss drugs